Reckitt Benckiser Group (LON:RB) received a GBX 9,000 ($117.60) target price from research analysts at JPMorgan Chase & Co. in a research note issued to investors on Thursday, Borsen Zeitung reports. The firm presently has a “buy” rating on the stock. JPMorgan Chase & Co.‘s price objective suggests a potential upside of 36.47% from the stock’s previous close.

RB has been the subject of a number of other research reports. Kepler Capital Markets set a €14.00 ($16.28) target price on alstria office REIT and gave the stock a “neutral” rating in a research note on Tuesday, May 7th. Bryan, Garnier & Co reduced their target price on GlaxoSmithKline from GBX 1,710 ($22.34) to GBX 1,660 ($21.69) and set a “neutral” rating for the company in a research note on Thursday, May 2nd. Credit Suisse Group restated a “hold” rating on shares of FactSet Research Systems in a research note on Monday, July 8th. HSBC set a $46.00 price objective on Aqua America and gave the company a “buy” rating in a research note on Friday, June 28th. Finally, Goldman Sachs Group set a GBX 6,870 ($89.77) price objective on Reckitt Benckiser Group and gave the company a “neutral” rating in a research note on Tuesday, June 25th. Three research analysts have rated the stock with a sell rating, four have given a hold rating and twelve have assigned a buy rating to the stock. Reckitt Benckiser Group has an average rating of “Hold” and a consensus target price of GBX 7,211.11 ($94.23).

Shares of LON RB opened at GBX 6,595 ($86.18) on Thursday. The company has a debt-to-equity ratio of 80.49, a current ratio of 0.65 and a quick ratio of 0.47. The company has a market cap of $46.76 billion and a PE ratio of 21.64. The firm’s fifty day moving average is GBX 6,384.22. Reckitt Benckiser Group has a 12-month low of GBX 5,559 ($72.64) and a 12-month high of GBX 7,174 ($93.74).

In other news, insider Christopher Sinclair bought 1,076 shares of the business’s stock in a transaction on Thursday, May 23rd. The shares were bought at an average price of GBX 6,375 ($83.30) per share, with a total value of £68,595 ($89,631.52). Also, insider Adrian Nevil Hennah sold 13,701 shares of the business’s stock in a transaction that occurred on Friday, May 10th. The shares were sold at an average price of GBX 6,143 ($80.27), for a total value of £841,652.43 ($1,099,767.97).

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

Featured Article: Growth Stocks

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.